Risk Factors Analysis and Survival Prediction Model Establishment of Patients with Lung Adenocarcinoma Based on Different Pyroptosis-related Gene Subtypes

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2023 Dec 19

PMID 38111060

Authors

Ziang Wen

Bei Pei

Longfei Dai

Peng Lu

Xiangyu Li

Chengxin Zhang

Shenglin Ge

Affiliations

Soon will be listed here.

Abstract

Background: Lung adenocarcinoma (LUAD) is a common cancer with a poor prognosis. Pyroptosis is an important process in the development and progression of LUAD. We analyzed the risk factors affecting the prognosis of patients and constructed a nomogram to predict the overall survival of patients based on different pyroptosis-related genes (PRGs) subtypes.

Methods: The genomic data of LUAD were downloaded from the TCGA and GEO databases, and all data were filtered and divided into TCGA and GEO cohorts. The process of data analysis and visualization was performed via R software. The data were classified based on different PRGs subtypes using the K-means clustering method. Then, the differentially expressed genes were identified between two different subtypes, and risk factors analysis, survival analysis, functional enrichment analysis, and immune cells infiltration landscape analysis were conducted. The COX regression analysis was used to construct the prediction model.

Results: Based on the PRGs of LUAD, the patients were divided into two subtypes. We found the survival probability of patients in subtype 1 is higher than that in subtype 2. The results of the logistics analysis showed that gene risk score was closely associated with the prognosis of LUAD patients. The results of GO analysis and KEGG analysis revealed important biological processes and signaling pathways involved in the differentially expressed proteins between the two subtypes. Then we constructed a prediction model of patients' prognosis based on 13 genes, including IL-1A, P2RX1, GSTM2, ESYT3, ZNF682, KCNF1, STK32A, HHIPL2, GDF10, NDC80, GSTA1, BCL2L10, and CCR2. This model was strongly related to the overall survival (OS) and also reflects the immune status in patients with LUAD.

Conclusion: In our study, we examined LUAD heterogeneity with reference to pyroptosis and found different prognoses between the two subtypes. And a novel prediction model was constructed to predict the OS of LUAD patients based on different PRGs signatures. The model has shown excellent predictive efficiency through validation.

References

Voronov E, Carmi Y, Apte R . The role IL-1 in tumor-mediated angiogenesis. Front Physiol. 2014; 5:114. PMC: 3975103. DOI: 10.3389/fphys.2014.00114. View

Xia X, Wang X, Cheng Z, Qin W, Lei L, Jiang J . The role of pyroptosis in cancer: pro-cancer or pro-"host"?. Cell Death Dis. 2019; 10(9):650. PMC: 6733901. DOI: 10.1038/s41419-019-1883-8. View

Neppl C, Keller M, Scherz A, Dorn P, Schmid R, Zlobec I . Comparison of the 7th and 8th Edition of the UICC/AJCC TNM Staging System in Primary Resected Squamous Cell Carcinomas of the Lung-A Single Center Analysis of 354 Cases. Front Med (Lausanne). 2019; 6:196. PMC: 6737333. DOI: 10.3389/fmed.2019.00196. View

He M, Yu W, Chang C, Miyamoto H, Liu X, Jiang K . Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways. Mol Oncol. 2020; 14(8):1779-1799. PMC: 7400793. DOI: 10.1002/1878-0261.12701. View

Wang F, Li G, Ning J, Chen L, Xu H, Kong X . Alcohol accumulation promotes esophagitis via pyroptosis activation. Int J Biol Sci. 2018; 14(10):1245-1255. PMC: 6097477. DOI: 10.7150/ijbs.24347. View

Wang W, Chen D, Jiang M, Xu B, Li X, Chu Y . Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins. J Dig Dis. 2018; 19(2):74-83. DOI: 10.1111/1751-2980.12576. View

Salven P, Hattori K, Heissig B, Rafii S . Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 2002; 16(11):1471-3. DOI: 10.1096/fj.02-0134fje. View

Chen X, He W, Hu L, Li J, Fang Y, Wang X . Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016; 26(9):1007-20. PMC: 5034106. DOI: 10.1038/cr.2016.100. View

Yu F, Tan W, Chen Z, Shen X, Mo X, Mo X . Nitidine chloride induces caspase 3/GSDME-dependent pyroptosis by inhibting PI3K/Akt pathway in lung cancer. Chin Med. 2022; 17(1):115. PMC: 9524076. DOI: 10.1186/s13020-022-00671-y. View

10.

Hu H, Yang M, Dong W, Yin B, Ding J, Huang B . A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer. Front Oncol. 2022; 12:873725. PMC: 9099437. DOI: 10.3389/fonc.2022.873725. View

11.

Sedighzadeh S, Khoshbin A, Razi S, Keshavarz-Fathi M, Rezaei N . A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications. Transl Lung Cancer Res. 2021; 10(4):1889-1916. PMC: 8107755. DOI: 10.21037/tlcr-20-1241. View

12.

Lee E, Son D, Kim S, Lee J, Jo J, Han J . Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res. 2008; 14(22):7397-404. DOI: 10.1158/1078-0432.CCR-07-4937. View

13.

Elaraj D, Weinreich D, Varghese S, Puhlmann M, Hewitt S, Carroll N . The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res. 2006; 12(4):1088-96. DOI: 10.1158/1078-0432.CCR-05-1603. View

14.

Xu F, Cui W, Wei Y, Cui J, Qiu J, Hu L . Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling. J Exp Clin Cancer Res. 2018; 37(1):207. PMC: 6116548. DOI: 10.1186/s13046-018-0878-0. View

15.

Dong J, Hu Z, Wu C, Guo H, Zhou B, Lv J . Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet. 2012; 44(8):895-9. PMC: 6628171. DOI: 10.1038/ng.2351. View

16.

Tang S, Wu M, Wong R, Liu Y, Tang L, Lai C . Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer. Cancer. 2011; 117(14):3209-21. DOI: 10.1002/cncr.25875. View

17.

Wang P, Wang Z, Zhu L, Sun Y, Castellano L, Stebbing J . A pyroptosis-related lncRNA signature in bladder cancer. Cancer Med. 2022; 12(5):6348-6364. PMC: 10028168. DOI: 10.1002/cam4.5344. View

18.

Chaft J, Rimner A, Weder W, Azzoli C, Kris M, Cascone T . Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 2021; 18(9):547-557. PMC: 9447511. DOI: 10.1038/s41571-021-00501-4. View

19.

Wang W, Liu F, Wang C, Wang C, Tang Y, Jiang Z . Glutathione S-transferase A1 mediates nicotine-induced lung cancer cell metastasis by promoting epithelial-mesenchymal transition. Exp Ther Med. 2017; 14(2):1783-1788. PMC: 5526173. DOI: 10.3892/etm.2017.4663. View

20.

Teng J, Mei Q, Zhou X, Tang Y, Xiong R, Qiu W . Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-κB/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer. Cancers (Basel). 2020; 12(1). PMC: 7017302. DOI: 10.3390/cancers12010193. View